Structural characterisation of the new brain imaging agent, [<sup>99m</sup>Tc][TcO(L)], H<sub>3</sub>L =N-4-oxopentan-2-ylidene-N′-pyrrol-2-ylmethylethane-1,2-diamine
作者:Gillian F. Morgan、Ulrich Abram、Guy Evrard、Francois Durant、Marcel Deblaton、Pierre Clemens、Paul Van den Broeck、John R. Thornback
DOI:10.1039/c39900001772
日期:——
Characterisation of [TcO(L)], a novel technetium complex currently undergoing Phase II clinical trial evaluation for cerebral perfusion, is reported.